Clinical trial Recruiting at 1 site Observational Ages 40 to 80

Characterizing lung interstitial and airway diseases to improve diagnosis and care

Official title: Establishment of Diagnosis and Classification System for Lung Interstitial and Airway Diseases (LIAD)

Run by Xiangya Hospital of Central South University · NCT06987266 · Data updated 2026-11-12

This multicenter study will look at how interstitial lung disease and airway disease occur together and with other conditions, then create clearer diagnostic criteria and see how these diseases behave over time.

Quick facts

Study typeObservational
Ages40 Years to 80 Years
SexAll
Enrollment900 (estimated)
SponsorXiangya Hospital of Central South University
Academic / other
Locations1 site (Changsha, Hunan)
StatusRecruiting
StartedMay 20, 2025
Main results expectedNovember 30, 2028
Study endsNovember 30, 2028
Registry record updatedAugust 24, 2026
Trial IDNCT06987266 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 40–80 with COPD, idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, or related conditions who have hospitalization records or outpatient diagnoses and can complete pulmonary function tests and CT imaging.

Probably not a fit

Patients whose disease does not involve ILD or airway disease, or who do not meet the imaging/function criteria, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will start with a large retrospective review from 9 hospitals covering about 10,000 cases to describe how ILD and airway diseases co-occur and relate to other lung conditions. They will develop classification and diagnostic criteria based on these findings. Next, a prospective, disease-specific cohort of about 900 patients will be followed for up to 2 years to observe prognosis, identify prognostic factors, and assess comorbidity severity. The study will also examine current treatments and associated medical costs through cost-effectiveness analyses over a total 4-year period (2024–2028).

Why it matters

Potential benefit: If successful, the work could standardize how ILD and airway diseases are diagnosed and managed, potentially improving care and resource use.

How similar studies have gone: Previous studies have shown that similar approaches can reveal patterns in comorbidity and improve classification, though this specific combined ILD/airway framework is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. age between 40-80 years old;
2. inpatients with an admission diagnosis of COPD, Idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, patients with the following diagnoses were screened by chest CT (slice thickness ≤1.5 mm) during hospitalization and by in-hospital or prior pulmonary function;
3. Inpatients who meet the criteria can complete pulmonary function tests and chest HRCT examinations within one month before expected discharge (excluding hospitalized patients with stable interstitial lung disease or airway disorders);
4. among outpatients, patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, COPD with pulmonary interstitial abnormalities, idiopathic pulmonary fibrosis with airway lesions, nonspecific interstitial pneumonia with airway lesions, pulmonary fibrosis with emphysema syndrome were diagnosed through chest CT (layer thickness ≤1.5mm) and lung function;
5. provide informed consent.

Exclusion Criteria:

1. expected survival less than 12 months;
2. planned lung transplantation or pneumonectomy within 12 months;
3. pregnant or lactating women;
4. Has previously undergone lobectomy or received thoracic radiotherapy.

Where it's running

  • Xiangya Hospital
    Changsha, Hunan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.